Literature DB >> 22933545

Maternal lipid profile during early pregnancy and pregnancy complications and outcomes: the ABCD study.

Tanja G M Vrijkotte1, Náthalie Krukziener, Barbara A Hutten, Karlijn C Vollebregt, Manon van Eijsden, Marcel B Twickler.   

Abstract

CONTEXT: Elevated lipid levels during late pregnancy are associated with complications and adverse outcome for both mother and newborn. However, it is inconclusive whether a disturbed lipid profile during early pregnancy has similar negative associations.
OBJECTIVE: Our objective was to investigate whether nonfasting maternal total cholesterol and triglyceride levels during early pregnancy are associated with six major adverse pregnancy outcomes.
METHODS: Data were derived from the Amsterdam Born Children and Their Development (ABCD) cohort study. Random blood samples of nonfasting total cholesterol and triglyceride levels were determined during early gestation (median = 13, interquartile range = 12-14 wk). Outcome measures were pregnancy-induced hypertension (PIH), preeclampsia, preterm birth, small/large for gestational age (SGA/LGA), and child loss. Only nondiabetic women with singleton deliveries were included; the baseline sample consisted of 4008 women. Analysis for PIH and preeclampsia were performed in nulliparous women only (n = 2037).
RESULTS: Mean (sd) triglyceride and total cholesterol levels were 1.33 (0.55) and 4.98 (0.87) mmol/liter, respectively. The incidence of pregnancy complications and perinatal outcomes were as follows: PIH, 4.9%; preeclampsia, 3.7%; preterm birth, 5.3%; SGA, 9.3%; LGA, 9.3%; and child loss, 1.4%. After adjustments, every unit increase in triglycerides was linearly associated with an increased risk of PIH [odds ratio (OR) = 1.60, P = 0.021], preeclampsia (OR = 1.69, P = 0.018), LGA (OR = 1.48, P < 0.001), and induced preterm delivery (OR = 1.69, P = 0.006). No associations were found for SGA or child loss. Total cholesterol was not associated with any of the outcome measures.
CONCLUSIONS: Elevated maternal triglyceride levels measured during early pregnancy are associated with pregnancy complications and adverse pregnancy outcomes. These results suggest that future lifestyle programs in women of reproductive age with a focus on lowering triglyceride levels (i.e. diet, weight reduction, and physical activity) may help to prevent hypertensive complications during pregnancy and adverse birth outcomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22933545     DOI: 10.1210/jc.2012-1295

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  85 in total

1.  Maternal dyslipidemia during early pregnancy and epigenetic ageing of the placenta.

Authors:  Deepika Shrestha; Tsegaselassie Workalemahu; Fasil Tekola-Ayele
Journal:  Epigenetics       Date:  2019-06-14       Impact factor: 4.528

2.  Maternal plasma cholesterol and duration of pregnancy: A prospective cohort study in Ghana.

Authors:  Brietta M Oaks; Christine P Stewart; Kevin D Laugero; Seth Adu-Afarwuah; Anna Lartey; Stephen A Vosti; Per Ashorn; Kathryn G Dewey
Journal:  Matern Child Nutr       Date:  2016-12-27       Impact factor: 3.092

3.  The -93T/G LPL Promoter Polymorphism Is Associated With Lower Third-Trimester Triglycerides in Pregnant African American Women.

Authors:  Mandy J Schmella; Robert E Ferrell; Marcia J Gallaher; David L Lykins; Andrew D Althouse; James M Roberts; Carl A Hubel
Journal:  Biol Res Nurs       Date:  2015-01-07       Impact factor: 2.522

Review 4.  Maternal cholesterol levels during gestation: boon or bane for the offspring?

Authors:  V S Jayalekshmi; Surya Ramachandran
Journal:  Mol Cell Biochem       Date:  2020-09-22       Impact factor: 3.396

5.  High cholesterol dietary intake during pregnancy is associated with large for gestational age in a sample of low-income women of Rio de Janeiro, Brazil.

Authors:  Maria Beatriz Trindade de Castro; Dayana Rodrigues Farias; Jaqueline Lepsch; Roberta Hack Mendes; Aline Alves Ferreira; Gilberto Kac
Journal:  Matern Child Nutr       Date:  2016-10-03       Impact factor: 3.092

6.  Effect of maternal lipid profile, C-peptide, insulin, and HBA1c levels during late pregnancy on large-for-gestational age newborns.

Authors:  Ruo-Lin Hou; Huan-Huan Zhou; Xiao-Yang Chen; Xiu-Min Wang; Jie Shao; Zheng-Yan Zhao
Journal:  World J Pediatr       Date:  2014-05-07       Impact factor: 2.764

7.  Differences in First-Trimester Maternal Metabolomic Profiles in Pregnancies Conceived From Fertility Treatments.

Authors:  Tianyanxin Sun; Bora Lee; Jason Kinchen; Erica T Wang; Tania L Gonzalez; Jessica L Chan; Jerome I Rotter; Yii-Der Ida Chen; Kent Taylor; Mark O Goodarzi; Stephen S Rich; Charles R Farber; John Williams; Margareta D Pisarska
Journal:  J Clin Endocrinol Metab       Date:  2019-04-01       Impact factor: 5.958

Review 8.  Management of Hypercholesterolemia in Pregnant Women with Atherosclerotic Cardiovascular Disease.

Authors:  Aneesha Thobani; Lauren Hassen; Laxmi S Mehta; Anandita Agarwala
Journal:  Curr Atheroscler Rep       Date:  2021-08-04       Impact factor: 5.113

9.  Early pregnancy dyslipidemia is associated with placental DNA methylation at loci relevant for cardiometabolic diseases.

Authors:  Marion Ouidir; Xuehuo Zeng; Tsegaselassie Workalemahu; Deepika Shrestha; Katherine L Grantz; Pauline Mendola; Cuilin Zhang; Fasil Tekola-Ayele
Journal:  Epigenomics       Date:  2020-07-17       Impact factor: 4.778

10.  Is the atherosclerotic phenotype of preeclamptic placentas due to altered lipoprotein concentrations and placental lipoprotein receptors? Role of a small-for-gestational-age phenotype.

Authors:  Marta R Hentschke; Carlos E Poli-de-Figueiredo; Bartira E Pinheiro da Costa; Lesia O Kurlak; Paula J Williams; Hiten D Mistry
Journal:  J Lipid Res       Date:  2013-07-29       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.